Equity

IHE

iShares U.S. Pharmaceuticals ETF

Visit Portfolio Tool
Add to Compare
  • NAV as of Apr 15, 2024 $63.58
    52 WK: 55.55 - 69.49
  • 1 Day NAV Change as of Apr 15, 2024 -0.18 (-0.28%)
  • NAV Total Return as of Apr 15, 2024 YTD: 3.35%
  • Fees as stated in the prospectus Expense Ratio: 0.40%

Overview

Why IHE?

1. Exposure to U.S. companies that manufacture prescription or over-the-counter drugs or vaccines

 

2. Targeted access to domestic pharmaceutical stocks

 

3. Use to express a sector view

INVESTMENT OBJECTIVE

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.
Loading